47 results on '"Durier, Christine"'
Search Results
2. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination
3. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial
4. Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study
5. Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years
6. A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project
7. Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination
8. A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox
9. A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults
10. Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination
11. Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials
12. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients
13. Social and Behavioral Consequences of Participation in HIV Preventive Vaccine Trials in the ANRS COHVAC Cohort
14. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial
15. Long-term CD4+ and CD8+ T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16)
16. Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial
17. Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study
18. Impact de la participation à un essai vaccinal préventif du VIH : la cohorte française ANRS/VRI COHVAC
19. Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers
20. High-pressure treatment of cloudy apple juice
21. Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03A adjuvant in HIV-1-infected adults
22. On the use of magnitude of reduction in HIV-1 RNA in clinical trials: statistical analysis and potential biases
23. Hepatitis B e Antigen (HBeAg) Rapid Test and Alanine Aminotransferase Level–Based Algorithm to Identify Pregnant Women at Risk of HBV Mother-to-Child Transmission: The ANRS 12345 TA PROHM Study
24. IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy—results from the ANRS CO4 cohort
25. Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial
26. Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048–079 Trials)*
27. Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults
28. Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals
29. Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients
30. Somatotropin treatment does not affect nonesterified fatty acid response to adrenergic injections in underfed or overfed nonlactating cows
31. Use of central composite experimental design for the development ofBradyrhizobium japonicum liquid inoculants
32. Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial
33. Assessment of the virulence of Listeria monocytogenes: agreement between a plaque-forming assay with HT-29 cells and infection of immunocompetent mice
34. Motivational interviewing training for medical students: A pilot pre-post feasibility study
35. Impact of early cART on HIV blood and semen compartments at the time of primary infection
36. Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype
37. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients.
38. Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients: Results From FHDH ANRS CO4
39. Long-term immunogenicity of two doses of 2009 AH1N1v vaccine with and without AS03Aadjuvant in HIV-1-infected adults
40. Use of central composite experimental design for the development ofBradyrhizobium japonicumliquid inoculants
41. Update of the Long-term Follow-up of Healthy Volunteers from Preventive HIV-1 Vaccine Trials: ANRS COV1-COHVAC Cohort.
42. Long-term CD4+ and CD8+ T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16).
43. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
44. Social and Behavioral Consequences of Participation in HIV Preventive Vaccine Trials in the ANRS COHVAC Cohort.
45. Impact of early cART on HIV blood and semen compartments at the time of primary infection.
46. Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4.
47. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.